Pfizer Shares Rise on RBC Upgrade and Regulatory Updates
SentiSense · Published · Updated
Pfizer's stock price increased after receiving a positive RBC upgrade and news about its US labeling for the medicine HYMPAVZI. Investors are digestin...
Sign in to read the full story. Free accounts include 20 full reads a month.
Powered by SentiSense - Intelligent Market Analysis